NCT00535392 Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy Status COMPLETED Phase PHASE2
NCT00518570 Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD) Status COMPLETED Phase NA
NCT00505934 Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy Status COMPLETED Phase PHASE2
NCT00489281 Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders Status TERMINATED Phase PHASE2
NCT00438451 Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs Status COMPLETED Phase PHASE4
NCT00415376 Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases Status WITHDRAWN Phase NA
NCT00393614 Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA) Status UNKNOWN Phase PHASE4
NCT00376766 Clinical Trial : TROCC (Quick Oral Treatment of Cluster Epileptic Seizures) Status TERMINATED Phase PHASE3
NCT00370838 Comparison of Keppra and Clonidine in the Treatment of Tics Status COMPLETED Phase PHASE4
NCT00367432 A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures Status COMPLETED Phase PHASE3
NCT00361010 A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy Status COMPLETED Phase NA
NCT00324454 Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease Status COMPLETED Phase PHASE2
NCT00319605 Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam Status COMPLETED Phase N/A
NCT00307450 Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease Status COMPLETED Phase PHASE4
NCT00299611 Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder Status TERMINATED Phase PHASE2/PHASE3
NCT00291733 Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease Status UNKNOWN Phase PHASE2